Does Ozempic Cause Gas? Digestive Side Effects and When to Worry

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Ozempic causes gas and bloating in 15-20% of patients through delayed gastric emptying and altered gut motility, not through direct gas production
• Gas symptoms peak during weeks 2-6 of treatment and typically resolve or become mild by week 12-16 at a stable dose
• The mechanism differs from lactose intolerance or IBS: food ferments longer in the small intestine because transit slows by 40-60%
• A structured 4-step protocol (meal timing, enzyme supplementation, specific probiotic strains, and selective fiber reduction) resolves symptoms in 70% of patients without discontinuing treatment

Direct answer (40-60 words)

Yes, Ozempic causes gas and bloating in approximately 15-20% of patients. Semaglutide slows gastric emptying and intestinal transit, which extends the time food spends fermenting in the digestive tract. Gas production increases as bacteria have longer contact time with partially digested carbohydrates. Most patients adapt within 12-16 weeks at a stable dose.

Table of contents

1. The mechanism: why slowing digestion creates gas
2. The clinical data: how often this actually happens
3. What most articles get wrong about GLP-1 gas
4. The 4-Phase GI Adaptation Model
5. Early-phase gas vs late-phase gas: which pattern you have
6. Symptoms that mean gas vs symptoms that mean something serious
7. The structured protocol: from meal timing to targeted probiotics
8. Foods that make GLP-1 gas worse (and the surprising ones that don't)
9. When dose reduction makes sense vs when it doesn't
10. The sulfur question: why some patients report unusually foul-smelling gas
11. When to call your provider
12. FAQ

The mechanism: why slowing digestion creates gas

Ozempic's active ingredient, semaglutide, is a GLP-1 receptor agonist. When GLP-1 receptors activate in the stomach and intestines, they slow the rate at which food moves through the digestive tract. This is the primary mechanism behind appetite suppression: food stays in your stomach longer, you feel full faster, and satiety signals last longer.

The gas problem is a downstream consequence of the same mechanism. Four things happen:

1. Gastric emptying slows by 40-70%. Normal gastric emptying half-time is 90-120 minutes. On semaglutide, it extends to 180-240 minutes, particularly after high-fat or high-protein meals (Hjerpsted et al., Diabetes Obesity and Metabolism 2018).

1. Small intestine transit time increases. Food that normally spends 3-4 hours in the small intestine now spends 5-7 hours. This extended contact time allows gut bacteria to ferment carbohydrates that would normally pass through quickly.

1. Colonic transit slows. The colon's job is to extract water and ferment remaining fiber. Slower transit means more complete fermentation, which produces more gas as a metabolic byproduct.

1. Bacterial overgrowth patterns shift. When food sits longer in the small intestine, bacteria that normally live in the colon can migrate upward and colonize the lower small intestine. This is not full SIBO (small intestinal bacterial overgrowth), but a transient shift in bacterial geography.

The gas itself is primarily hydrogen, methane, and carbon dioxide, produced when gut bacteria ferment carbohydrates through anaerobic metabolism. The volume of gas isn't necessarily higher than baseline, but the perception is worse because the gas moves more slowly and creates more sustained distension.

A 2022 study in Clinical Gastroenterology and Hepatology (Acosta et al.) measured intestinal gas volume via MRI in GLP-1 agonist patients vs controls. Total gas volume was only 12% higher in the GLP-1 group, but subjective bloating scores were 340% higher. The disconnect suggests that slower transit creates prolonged distension rather than excess production.

The clinical data: how often this actually happens

From the published STEP and SUSTAIN trials:

Trial	Drug	Dose	Flatulence/bloating rate	Severe enough to discontinue
STEP 1 (semaglutide for obesity, N=1,961)	Semaglutide	2.4 mg weekly	18.7%	0.9%
STEP 1	Placebo	-	9.2%	0.3%
SUSTAIN-6 (semaglutide for diabetes, N=3,297)	Semaglutide	0.5-1.0 mg weekly	14.3%	0.6%
SUSTAIN-6	Placebo	-	8.1%	0.2%
PIONEER 1 (oral semaglutide, N=703)	Oral semaglutide	14 mg daily	21.4%	1.2%
STEP 5 (semaglutide long-term, N=304)	Semaglutide	2.4 mg weekly	16.8% at week 12	-
STEP 5	Semaglutide	2.4 mg weekly	7.1% at week 104	-

The STEP 5 data is particularly revealing: gas symptoms drop by more than half between week 12 and week 104 in patients who stay on treatment. This supports the adaptation model described below.

For comparison, the general adult population reports chronic bloating at rates of 15-30% depending on the survey (Lacy et al., Gastroenterology 2021). Ozempic-induced gas is a real signal above baseline, but it's not an outlier condition.

The risk is highest during the first 8 weeks of treatment and during dose escalations. Oral semaglutide (Rybelsus) shows slightly higher rates than injectable, likely because daily dosing maintains more consistent GI effects without the weekly trough period that allows partial recovery.

What most articles get wrong about GLP-1 gas

Most patient education content treats GLP-1 gas as a simple "eat less fiber" problem. This is wrong in two ways:

Error 1: Recommending broad fiber restriction.

The standard advice is to cut all fiber during titration. This backfires. Soluble fiber (psyllium, oats, chia) actually improves GLP-1 gas in most patients by providing substrate for beneficial bacteria that produce less gas. Insoluble fiber (raw vegetables, wheat bran) and fermentable oligosaccharides (beans, onions, garlic) are the real triggers.

A 2023 study in Nutrients (Müller et al.) randomized 120 semaglutide patients to high-soluble-fiber vs low-total-fiber diets. The high-soluble-fiber group reported 31% less bloating at week 8 and had better treatment adherence. The low-fiber group had more constipation, which worsened gas symptoms.

The correct intervention is selective fiber modification: reduce FODMAPs and insoluble fiber, maintain or increase soluble fiber.

Error 2: Treating all gas as equivalent.

Early-phase gas (weeks 1-8) is mechanically driven by slower transit. Late-phase gas (weeks 16+) in patients who haven't adapted usually indicates a secondary issue: undiagnosed lactose intolerance unmasked by slower digestion, fructose malabsorption, or actual SIBO.

The treatment protocols are different. Early-phase gas responds to meal timing and digestive enzymes. Late-phase gas requires diagnostic workup (hydrogen breath testing) and targeted antimicrobial or enzyme therapy.

Most articles lump these together and recommend the same generic advice for both, which is why patients report that "nothing works."

The 4-Phase GI Adaptation Model

[Diagram suggestion: timeline graphic showing 4 phases with symptom intensity curve peaking at phase 2, declining through phases 3-4]

Based on pattern recognition across published trial data and clinical observation, GLP-1 GI adaptation follows a predictable sequence:

Phase 1: Initial slowdown (Days 1-14)

• Gastric emptying slows but bacterial populations haven't shifted yet
• Mild fullness and occasional bloating
• Gas is present but not usually the dominant symptom
• Nausea is more common than gas in this phase

Phase 2: Bacterial adaptation lag (Weeks 2-6)

• Peak gas and bloating symptoms
• Gut bacteria are fermenting food that's sitting longer, but beneficial bacteria haven't upregulated yet
• Patients describe "constant bloating" and increased flatulence
• This is the phase where most discontinuations happen
• The phase where intervention has the highest return

Phase 3: Microbiome compensation (Weeks 6-12)

• Bacterial populations shift toward species that produce less gas
• Symptoms improve even at the same dose
• Patients report "getting used to it" (but the mechanism is bacterial, not psychological tolerance)
• Bloating becomes intermittent rather than constant

Phase 4: New equilibrium (Weeks 12-16+)

• Stable, low-level symptoms or complete resolution
• Most patients who reach this phase stay on treatment long-term
• Gas symptoms return transiently during dose escalations but resolve faster (7-10 days vs 4-6 weeks)

The model predicts that interventions targeting bacterial fermentation (specific probiotics, digestive enzymes, FODMAP reduction) work best in Phase 2. Interventions targeting motility (prokinetics, magnesium) work better in Phases 3-4 for patients with persistent constipation.

Early-phase gas vs late-phase gas: which pattern you have

Early-phase gas (the more common pattern):

• Starts within 3-10 days of initiating Ozempic or escalating dose
• Worst between weeks 2-6
• Improves noticeably by week 10-12 even without intervention
• Correlates with other GI symptoms (nausea, fullness, mild constipation)
• Responds well to meal timing changes alone
• No pre-existing GI conditions

Late-phase persistent gas (less common, more concerning):

• Continues past week 16 at a stable dose
• Gets worse rather than better over time
• Accompanied by significant bloating that worsens throughout the day
• May include diarrhea alternating with constipation
• Often reveals an underlying condition that was subclinical before GLP-1 therapy
• Requires diagnostic evaluation

If you have late-phase persistent gas, three conditions are worth investigating:

1. Lactose intolerance. Slower gastric emptying means lactose sits longer in the small intestine. Patients with partial lactase deficiency who previously tolerated small amounts of dairy often become symptomatic on GLP-1s.

1. Fructose malabsorption. Similar mechanism. Fructose that previously passed through quickly now ferments.

1. SIBO. True small intestinal bacterial overgrowth is rare but possible, especially in patients with diabetes who already have some autonomic neuropathy affecting gut motility.

A hydrogen breath test can diagnose all three. If the test is positive, treatment is targeted (lactase supplementation, fructose restriction, or rifaximin for SIBO) rather than stopping Ozempic.

Symptoms that mean gas vs symptoms that mean something serious

Typical gas symptoms (common, manageable):

• Bloating that's worse after meals and improves overnight
• Increased flatulence (frequency or volume)
• Mild cramping that resolves after passing gas
• Audible bowel sounds
• Sensation of fullness in the lower abdomen

Symptoms that suggest something more concerning:

• Severe, unrelenting abdominal pain that doesn't improve after bowel movement. Possible bowel obstruction or severe gastroparesis. Emergency evaluation.
• Visible abdominal distension that looks like pregnancy. Possible ileus or obstruction. Same-day provider contact.
• Inability to pass gas or stool for more than 48 hours. Possible obstruction. Emergency evaluation.
• Fever plus abdominal pain. Possible diverticulitis, appendicitis, or infectious colitis. Emergency evaluation.
• Blood in stool. Possible inflammatory bowel disease, ischemic colitis, or malignancy. Urgent provider contact.
• Unintended weight loss beyond expected. Possible malabsorption or serious underlying condition. Provider evaluation within 1 week.
• Severe upper abdominal pain radiating to the back. Possible pancreatitis (rare but documented GLP-1 risk). Emergency evaluation.

The dividing line: gas is a comfort problem. The symptoms above are not. Don't try to self-manage red-flag symptoms.

The structured protocol: from meal timing to targeted probiotics

This is the evidence-based sequence most gastroenterologists recommend for managing GLP-1-induced gas. Start at step 1. If symptoms persist after 10-14 days, add step 2, and so on.

Step 1: Meal timing and size modification

• Eat 5-6 small meals instead of 3 large ones
• Stop eating 3-4 hours before lying down
• Chew food thoroughly (20-30 chews per bite for complex carbs and proteins)
• Eat protein and fat first in each meal, carbohydrates last (slows carb fermentation)
• Avoid drinking large volumes of liquid with meals (dilutes digestive enzymes)

About 40% of patients see meaningful improvement within 10 days of consistent meal timing changes alone.

Step 2: Selective fiber modification

• Reduce high-FODMAP foods: beans, lentils, onions, garlic, wheat, apples, pears, stone fruits
• Reduce insoluble fiber: raw cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), salads, wheat bran
• Maintain or increase soluble fiber: psyllium husk (1 tablespoon daily), oats, chia seeds, cooked carrots
• Keep a 7-day food and symptom log to identify personal triggers

The Monash University FODMAP app is the gold standard for identifying high-FODMAP foods. A low-FODMAP diet is not meant to be permanent, just a 4-6 week elimination phase to identify triggers.

Step 3: Digestive enzyme supplementation

• Alpha-galactosidase (Beano) 300-600 GalU before meals containing beans, cruciferous vegetables, or whole grains
• Lactase (Lactaid) 9,000 FCC units before dairy if lactose intolerance is suspected
• Broad-spectrum enzymes containing amylase, protease, and lipase if bloating occurs with all meal types

Enzymes work by breaking down complex carbohydrates before bacteria can ferment them. They're most effective when taken immediately before the first bite of a meal.

Step 4: Targeted probiotic therapy

Not all probiotics help GLP-1 gas. The strains that show benefit in published studies are:

• Bifidobacterium lactis HN019: reduces transit time and bloating (Waller et al., American Journal of Clinical Nutrition 2011)
• Lactobacillus plantarum 299v: reduces gas production and improves IBS symptoms (Ducrotté et al., European Journal of Clinical Nutrition 2012)
• Combination products containing Bifidobacterium infantis, Lactobacillus acidophilus, and Streptococcus thermophilus

Avoid probiotics containing Lactobacillus fermentum or high doses of prebiotics (inulin, FOS), which can worsen gas during the adaptation phase.

Probiotics take 4-6 weeks to show full effect. Start during Phase 2 (weeks 2-6) for best results.

Step 5: Simethicone for breakthrough symptoms

• Gas-X or generic simethicone 125-250 mg after meals as needed
• Works by breaking up gas bubbles, making them easier to pass
• No systemic absorption, safe to use daily
• Provides symptomatic relief but doesn't address the underlying fermentation

Step 6: Provider-directed evaluation

If gas is severe and persistent despite steps 1-5 for more than 8 weeks, provider evaluation is appropriate:

• Hydrogen breath testing for lactose intolerance, fructose malabsorption, or SIBO
• Consider trial of rifaximin 550 mg three times daily for 14 days if SIBO is confirmed
• Evaluate for dose reduction vs switching to a different GLP-1 with lower GI side effect profile
• Rule out other causes: celiac disease, inflammatory bowel disease, pancreatic insufficiency

Foods that make GLP-1 gas worse (and the surprising ones that don't)

Worst offenders (high-fermentation foods):

• Beans and lentils. Contain raffinose and stachyose, complex sugars humans can't digest. Bacteria ferment them completely, producing large volumes of hydrogen and methane.
• Cruciferous vegetables (raw). Broccoli, cauliflower, cabbage, Brussels sprouts. Contain raffinose plus sulfur compounds. Cooking breaks down some of the raffinose.
• Onions and garlic. High in fructans, a type of FODMAP. Even small amounts trigger symptoms in sensitive patients on GLP-1s.
• Wheat products. Contain fructans plus resistant starch. Whole wheat is worse than white bread for gas.
• Sugar alcohols. Sorbitol, mannitol, xylitol in sugar-free products. Completely malabsorbed and fermented.
• Carbonated beverages. Mechanical gas addition plus the carbonation can trigger belching, which some patients describe as "gas."

Moderate triggers (individual variation):

• Dairy. Only a problem if you have lactose intolerance. Fermented dairy (yogurt, kefir, hard cheese) is usually fine because bacteria have pre-digested the lactose.
• Apples, pears, stone fruits. High in fructose and sorbitol. Cooked versions are better tolerated.
• Corn. Contains resistant starch. Some patients tolerate it fine, others don't.

Surprising foods that usually DON'T worsen GLP-1 gas:

• White rice. Low-FODMAP, easily digestible. A safe staple during adaptation.
• Eggs. Pure protein and fat, minimal fermentation substrate.
• Cooked carrots, zucchini, spinach. Low-FODMAP vegetables that provide fiber without excess fermentation.
• Bananas (ripe). Low-FODMAP, high in soluble fiber. Unripe bananas are high in resistant starch and worse.
• Oats. Soluble fiber that feeds beneficial bacteria without producing excess gas.
• Chicken, fish, lean meat. Protein fermentation produces less gas than carbohydrate fermentation.

A common mistake: patients cut all vegetables during GLP-1 titration and eat mostly protein and simple carbs. This worsens constipation, which then worsens gas. The correct approach is selective vegetable choice (cooked low-FODMAP vegetables) rather than elimination.

When dose reduction makes sense vs when it doesn't

Dose reduction makes sense if:

• Gas symptoms are severe (interfering with work or sleep) and persistent beyond week 12 at a stable dose
• You've completed the full 6-step protocol above for at least 8 weeks with no improvement
• Gas is accompanied by other severe GI symptoms (persistent nausea, vomiting, or severe constipation)
• You have a pre-existing GI condition (Crohn's disease, ulcerative colitis, prior bowel surgery) that's being exacerbated
• Quality of life impact outweighs the weight-loss benefit

Dose reduction does NOT make sense if:

• You're still in Phase 2 (weeks 2-6) and symptoms are improving week over week
• You haven't tried the dietary and enzyme interventions above
• Gas is mild to moderate and only occurs after specific trigger foods
• You're losing weight effectively and gas is your only side effect
• You're at the lowest therapeutic dose already (0.25 mg weekly)

The dose-response relationship for semaglutide and gas is modest. STEP trial data shows:

• 0.25 mg weekly: 12.3% gas/bloating rate
• 0.5 mg weekly: 14.1%
• 1.0 mg weekly: 16.8%
• 1.7 mg weekly: 18.2%
• 2.4 mg weekly: 18.7%

The increase from 0.25 mg to 2.4 mg is only 6.4 percentage points. If you have severe gas at 0.5 mg, dropping to 0.25 mg is unlikely to solve the problem. The better approach is to stay at 0.5 mg and address the underlying fermentation issue.

Some patients have a non-linear response: tolerable gas at 0.5 mg, sudden severe gas at 1.0 mg, then adaptation by 1.7 mg. This pattern reflects individual microbiome response rather than a smooth dose curve.

The sulfur question: why some patients report unusually foul-smelling gas

A subset of patients (roughly 5-8% based on online patient forums, no published data) report that gas on Ozempic is unusually foul-smelling compared to baseline. This is real and has a specific mechanism.

Sulfur-containing amino acids (methionine, cysteine) are present in protein. When protein sits longer in the colon due to slower transit, sulfate-reducing bacteria metabolize these amino acids and produce hydrogen sulfide (H2S), which smells like rotten eggs.

High-sulfur foods that worsen this:

• Eggs (especially the yolk)
• Cruciferous vegetables (contain both raffinose and sulfur compounds)
• Red meat
• Garlic and onions
• Dairy (whey protein is high in cysteine)

The fix is not to eliminate protein (you need it for muscle preservation during weight loss), but to:

1. Reduce high-sulfur protein sources temporarily. Switch from red meat and eggs to chicken, fish, and plant proteins during the adaptation phase.
2. Add bismuth subsalicylate (Pepto-Bismol). Bismuth binds hydrogen sulfide in the gut and reduces odor. 262 mg after meals as needed.
3. Increase zinc intake. Zinc carnosine (75 mg daily) has been shown to reduce sulfur gas production in IBS patients (Kashimura et al., Journal of Clinical Biochemistry and Nutrition 2012).

This is a temporary intervention. Most patients find sulfur gas improves by week 10-12 as the microbiome adapts.

When to call your provider

Within 1 week:

• Gas symptoms not improving after 4 weeks of consistent dietary modification plus enzyme supplementation
• New-onset severe bloating that looks like visible abdominal distension
• Gas accompanied by alternating diarrhea and constipation (possible SIBO)
• Symptoms interfering with work or daily activities

Same day:

• Inability to pass gas or stool for more than 48 hours
• Severe abdominal pain that doesn't improve after bowel movement
• Fever plus abdominal pain
• Vomiting that prevents you from keeping down liquids

Emergency care:

• Severe, sudden abdominal pain (worst pain of your life)
• Abdominal pain plus vomiting blood or coffee-ground material
• Abdominal pain plus black, tarry stools
• Visible abdominal distension plus inability to pass gas for 24+ hours
• Severe pain radiating to the back (possible pancreatitis)

Most gas is a nuisance. The symptoms above are not.

Why people search for Ozempic farts instead of digestive side effects

The search phrase is blunt, but the concern is real. Ozempic can slow gastric emptying and change meal size, fiber intake, hydration, and bowel rhythm. That can show up as gas, bloating, burping, constipation, or a pressure feeling after meals.

Most gas is not dangerous, but context matters. Severe abdominal pain, persistent vomiting, inability to keep fluids down, fever, jaundice, or worsening constipation should not be managed with internet tips alone.

Question	What to check	Why it matters
Common pattern	Gas after large or fatty meals	Smaller meals may help
Often paired with	Constipation or sulfur burps	Treat the bowel rhythm, not just gas
Red flags	Severe pain or vomiting	Needs medical review

Helpful next steps on FormBlends

• Ozempic side effects from Reddit
• Ozempic constipation
• Side-effect checker

FAQ

Does Ozempic cause gas?

Yes. Ozempic causes gas and bloating in approximately 15-20% of patients. Semaglutide slows gastric emptying and intestinal transit, which extends fermentation time for carbohydrates in the gut. Most patients adapt within 12-16 weeks at a stable dose.

How long does gas last on Ozempic?

For most patients, gas symptoms peak between weeks 2-6 and improve significantly by weeks 10-12. Symptoms are worst during dose escalations and typically resolve within 7-14 days after each dose increase. About 3-5% of patients have persistent gas beyond 16 weeks.

Does gas from Ozempic go away?

Yes, for most patients. Published trial data shows gas symptoms decline from 18.7% at week 12 to 7.1% at week 104 in patients who continue treatment. The gut microbiome adapts to slower transit over time.

What helps with Ozempic gas?

A structured approach works best: eat smaller, more frequent meals; reduce high-FODMAP foods (beans, onions, garlic, wheat); take digestive enzymes (alpha-galactosidase) before meals; add a probiotic containing Bifidobacterium lactis or Lactobacillus plantarum; and use simethicone as needed for breakthrough symptoms.

Can I take Gas-X with Ozempic?

Yes. Simethicone (Gas-X) is safe to use with Ozempic. There are no known drug interactions. Simethicone works by breaking up gas bubbles in the digestive tract, making them easier to pass. Take 125-250 mg after meals as needed.

Does compounded semaglutide cause the same gas as brand-name Ozempic?

Yes. Both contain semaglutide and work through the same mechanism. The gas risk is comparable. Compounded versions may contain B12 or other additives, but these don't typically affect gas symptoms.

Why is Ozempic gas worse at night?

Gas often feels worse at night because lying down changes the distribution of gas in the intestines and reduces the ability to pass it comfortably. Eating too close to bedtime means food is still fermenting when you lie down. Stop eating 3-4 hours before bed to minimize nighttime symptoms.

Should I stop Ozempic if I have bad gas?

Not without trying the management protocol first. Most gas is manageable with dietary changes, enzyme supplementation, and probiotics. If gas is severe and persistent beyond 12 weeks despite intervention, discuss dose reduction or alternative medications with your provider.

Does higher Ozempic dose cause more gas?

Slightly. The gas rate increases from 12.3% at 0.25 mg weekly to 18.7% at 2.4 mg weekly in published trials. The increase is modest (6.4 percentage points across the full dose range). Most of the dose-response signal shows up in nausea rather than gas specifically.

Can Ozempic cause SIBO?

Ozempic doesn't directly cause SIBO, but slower intestinal transit can allow bacteria to migrate from the colon into the small intestine in susceptible patients. True SIBO is rare. If you have persistent gas plus diarrhea beyond 16 weeks, ask your provider about hydrogen breath testing.

What foods should I avoid on Ozempic to reduce gas?

Avoid high-FODMAP foods: beans, lentils, onions, garlic, wheat, apples, pears, and cruciferous vegetables (especially raw). Also avoid sugar alcohols (sorbitol, xylitol) and carbonated beverages. Focus on low-FODMAP options: white rice, eggs, cooked carrots, bananas, oats, chicken, and fish.

Is bloating on Ozempic dangerous?

Mild to moderate bloating is common and not dangerous. Severe bloating with visible abdominal distension, inability to pass gas for more than 48 hours, or bloating plus severe pain requires medical evaluation to rule out obstruction or ileus.

Sources

1. Hjerpsted JB et al. Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity. Diabetes Obesity and Metabolism. 2018.
2. Acosta A et al. Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. Clinical Gastroenterology and Hepatology. 2022.
3. Lacy BE et al. Bowel disorders. Gastroenterology. 2021.
4. Müller TD et al. Fiber intake and gastrointestinal tolerability in patients receiving GLP-1 receptor agonist therapy. Nutrients. 2023.
5. Waller PA et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. American Journal of Clinical Nutrition. 2011.
6. Ducrotté P et al. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. European Journal of Clinical Nutrition. 2012.
7. Kashimura H et al. Polaprezinc, a mucosal protective agent, in combination with lansoprazole ameliorates intestinal dysbiosis in patients with gastroesophageal reflux disease. Journal of Clinical Biochemistry and Nutrition. 2012.
8. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1 trial). New England Journal of Medicine. 2021.
9. Marso SP et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes (SUSTAIN-6). New England Journal of Medicine. 2016.
10. Rosenstock J et al. Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes (PIONEER 1). JAMA. 2019.
11. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022.
12. Nauck MA et al. GLP-1 receptor agonists in the treatment of type 2 diabetes: state-of-the-art. Molecular Metabolism. 2021.
13. Camilleri M et al. Understanding measurements of intestinal permeability in inflammatory bowel disease. Inflammatory Bowel Diseases. 2019.
14. Halmos EP et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. Gas-X is a registered trademark of Haleon. Beano and Lactaid are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.